These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23900608)

  • 1. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
    Simone B; De Stefano V; Leoncini E; Zacho J; Martinelli I; Emmerich J; Rossi E; Folsom AR; Almawi WY; Scarabin PY; den Heijer M; Cushman M; Penco S; Vaya A; Angchaisuksiri P; Okumus G; Gemmati D; Cima S; Akar N; Oguzulgen KI; Ducros V; Lichy C; Fernandez-Miranda C; Szczeklik A; Nieto JA; Torres JD; Le Cam-Duchez V; Ivanov P; Cantu-Brito C; Shmeleva VM; Stegnar M; Ogunyemi D; Eid SS; Nicolotti N; De Feo E; Ricciardi W; Boccia S
    Eur J Epidemiol; 2013 Aug; 28(8):621-47. PubMed ID: 23900608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombophilia and venous thromboembolism in pregnancy: a meta-analysis of genetic risk.
    Ziakas PD; Poulou LS; Pavlou M; Zintzaras E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():106-11. PubMed ID: 26115054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.
    Hussein AS
    J Thromb Thrombolysis; 2012 Oct; 34(3):383-7. PubMed ID: 22528331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
    Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
    J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
    Segal JB; Brotman DJ; Necochea AJ; Emadi A; Samal L; Wilson LM; Crim MT; Bass EB
    JAMA; 2009 Jun; 301(23):2472-85. PubMed ID: 19531787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
    Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
    Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
    M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
    Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.
    Bucciarelli P; De Stefano V; Passamonti SM; Tormene D; Legnani C; Rossi E; Castaman G; Simioni P; Cini M; Martinelli I
    Blood; 2013 Oct; 122(15):2555-61. PubMed ID: 23913469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.
    de Paula Sabino A; Guimarães DA; Ribeiro DD; Paiva SG; Sant'Ana Dusse LM; das Graças Carvalho M; Fernandes AP
    J Thromb Thrombolysis; 2007 Dec; 24(3):261-6. PubMed ID: 17401546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
    Chamorro AJ; Marcos M; Hernández-García I; Calvo A; Mejia JC; Cervera R; Espinosa G
    Autoimmun Rev; 2013 Mar; 12(5):607-16. PubMed ID: 23207285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members.
    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
    Genet Med; 2011 Jan; 13(1):67-76. PubMed ID: 21150787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.